WALTHAM, Massachusetts – June 16, 2025 Scipher Medicine, a leading precision immunology company, today announced a strategic alliance with Grupo Amarey, a leading company in the representation and distribution of technologies, solutions, and services for the...
Partnership integrates Scipher’s PrismRA to deliver insights into therapy response segmentation WALTHAM, Mass.–(BUSINESS WIRE)–Scipher Medicine, a precision immunology company dedicated to transforming patient care through data-driven insights, today...
Collaboration combines Scipher’s unique RNAseq data, part of the largest non-oncology clinico-transcriptomic data lake and biobank, with InnoSIGN’s proprietary Comprehensive Pathway Analysis (CPA) platform to enhance the understanding of complex...
The partnership integrates Kythera’s enriched high-fidelity multi-source EHR and claims data assets with real-world clinical and genomic data from Scipher’s PrismRA® Test, revealing new insights for precision medicine advancements. Waltham, MA-April 15, 2025 – Scipher...
Waltham, MA – Jan. 13, 2025 – Scipher Medicine, a leader in precision medicine for autoimmune diseases, and Roivant, a global biopharmaceutical company that aims to improve the lives of patients by accelerating the development and commercialization of medicines that...
The partnership integrates transcriptome genomic data from Scipher’s PrismRA Test into OMNY’s EMR network, unlocking deeper patient insights for precision medicine advancements. Atlanta, Georgia – Jan. 9, 2025 – OMNY Health, the leading healthcare...
